Chronic Kidney Disease
Observed link between sleep apnea and CKD risk may be due to obesity
Although study results showed severe obstructive sleep apnea was associated with increased risk for incident chronic kidney disease, the risk was attenuated and no longer statistically significant after adjusting for obesity.
Study: Adverse drug reactions common, many deemed preventable, in patients with CKD
A study conducted in France found adverse drug reactions were common in patients with chronic kidney disease, most notably due antithrombotic agents, but researchers suggested many of these reactions may be preventable.
Many patients with CKD do not rely on nephrologists for treatment, advice
A study conducted in Pennsylvania revealed that many adults with chronic kidney disease utilized medical health care professionals other than nephrologists for related treatment and advice.
Clinicians review home dialysis, other interventions for US patients with CKD, COVID-19
The COVID-19 pandemic poses health risks for patients on chronic dialysis. With nearly 88% of these patients on in-center hemodialysis, managing risk for contracting or spreading the virus has been a challenge, according to a press release.
Study: Vitamin D agents deemed similar for treating coronary artery calcification in CKD
Researchers found no difference in coronary artery calcification progression between patients with chronic kidney disease and secondary hyperparathyroidism who were randomized to either calcitriol or paricalcitol.
More plant-based protein may slow kidney function decline in women older than 70 years
Older white women who consumed higher quantities of plant-based proteins had a slower yearly decline in eGFR, according to a study conducted in Australia.
Calcimimetic agents show short-term benefits for patients with CKD, but side effects vary
For patients with kidney disease, calcimimetic agents lowered parathyroid hormone levels in the short term, with each agent consisting of a different side-effect profile, according to a systematic study review.
Top in endocrinology: Dapagliflozin, new integrated continuous glucose monitor
New data from the DAPA-HF trial showed that dapagliflozin was associated with a 32% lower risk for new-onset type 2 diabetes among patients with heart failure. It was the top story in endocrinology last week.
HF after diabetes diagnosis raises 5-year mortality risk, lowers life span
Patients who developed HF at any time after their diabetes diagnosis had the greatest relative and absolute risk for death at 5 years compared with those with diabetes who had other CV or renal diagnoses, researchers reported.
Substituting red meat with alternate dietary proteins may reduce kidney disease risk
While the consumption of greater quantities of red meat was associated with a higher incidence of chronic kidney disease, researchers from Iran suggest that making substitutions with other sources of dietary protein may reduce the risk.